{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:06:18Z","timestamp":1784070378415,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xkme.2026.101241","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:03:43Z","timestamp":1767686623000},"page":"101241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Large Deletion With a Large Impact: Homozygous 5,600 bp Deletion of the GALNT3 Gene Causing Hyperphosphatemic Tumoral Calcinosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Julia Maria","family":"Portmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-7983","authenticated-orcid":false,"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101241_bib1","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00250.2021","article-title":"Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo","volume":"321","author":"K\u00fcng","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.xkme.2026.101241_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-020-00659-6","article-title":"Congenital hyperphosphatemic conditions caused by the deficient activity of FGF23","volume":"108","author":"Ito","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.xkme.2026.101241_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.beem.2018.06.004","article-title":"Phosphate homeostasis disorders","volume":"32","author":"Christov","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.xkme.2026.101241_bib4","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.3390\/molecules26185504","article-title":"Polypeptide N-acetylgalactosaminyltransferase-associated phenotypes in mammals","volume":"26","author":"Kato","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.xkme.2026.101241_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00424-024-03046-4","article-title":"Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels","volume":"477","author":"Gerber","year":"2025","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.xkme.2026.101241_bib6","series-title":"GeneReviews [Internet]","article-title":"Hyperphosphatemic familial tumoral calcinosis","author":"Ramnitz","year":"2018"},{"key":"10.1016\/j.xkme.2026.101241_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fendo.2020.00293","article-title":"Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management","volume":"11","author":"Boyce","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xkme.2026.101241_bib8","article-title":"Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting","volume":"103S","author":"Bacchetta","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.xkme.2026.101241_bib9","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xkme.2026.101241_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.xkme.2026.101241_bib11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jbmr.2870","article-title":"Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome","volume":"31","author":"Ramnitz","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.xkme.2026.101241_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11914-015-0254-3","article-title":"Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action","volume":"13","author":"Folsom","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.xkme.2026.101241_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2011.08.030","article-title":"Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23","volume":"347","author":"Perwad","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.xkme.2026.101241_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000478-199308000-00004","article-title":"Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis","volume":"17","author":"Slavin","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.xkme.2026.101241_bib15","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/ndt\/gfu324","article-title":"Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing","volume":"29","author":"Shah","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl","key":"10.1016\/j.xkme.2026.101241_bib16","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0022034514529150","article-title":"Rare bone diseases and their dental, oral, and craniofacial manifestations","volume":"93","author":"Foster","year":"2014","journal-title":"J Dent Res"},{"key":"10.1016\/j.xkme.2026.101241_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.25259\/ijn_534_23","article-title":"GALNT3 mutation in hyperphosphatemic familial tumoral calcinosis - novel etiology of secondary amyloidosis","volume":"35","author":"Sharma","year":"2025","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.xkme.2026.101241_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40618-020-01203-x","article-title":"Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene","volume":"43","author":"Mahjoubi","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.xkme.2026.101241_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12863-014-0098-3","article-title":"Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature","volume":"15","author":"Rafaelsen","year":"2014","journal-title":"BMC Genet"},{"key":"10.1016\/j.xkme.2026.101241_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5582\/irdr.2020.03084","article-title":"A novel homozygous variant in exon 10 of the GALNT3 gene causing hyperphosphatemic familial tumoral calcinosis in a family from North India","volume":"10","author":"Dayal","year":"2021","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.xkme.2026.101241_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1297\/cpe.2022-0071","article-title":"A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a GALNT3 variant","volume":"32","author":"Nishimura-Kinoshita","year":"2023","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.xkme.2026.101241_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajmg.a.33337","article-title":"Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations","volume":"152A","author":"Ichikawa","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.xkme.2026.101241_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg2593","article-title":"Mechanisms of change in gene copy number","volume":"10","author":"Hastings","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.xkme.2026.101241_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00223-022-00969-x","article-title":"Use of teriparatide in hyperphosphatemic familial tumor calcinosis: evaluating the interaction between FGF23 and PTH on the phosphaturic effect","volume":"111","author":"Pallone","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.xkme.2026.101241_bib25","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/ajd.13750","article-title":"Therapeutic success of sodium thiosulfate in treating cutaneous calciphylaxis in a patient with hyperphosphataemic familial tumoral calcinosis","volume":"63","author":"Requena","year":"2022","journal-title":"Australas J Dermatol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:22:11Z","timestamp":1784067731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2590059526000026"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101241","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Large Deletion With a Large Impact: Homozygous 5,600 bp Deletion of the GALNT3 Gene Causing Hyperphosphatemic Tumoral Calcinosis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101241"}}